Literature DB >> 23448974

The liver in sepsis: patterns of response and injury.

Michael Bauer1, Adrian T Press, Michael Trauner.   

Abstract

PURPOSE OF REVIEW: Sepsis elicits profound changes in the concentrations of plasma proteins synthesized by liver parenchymal cells referred to as acute-phase proteins. Mechanisms controlling this orchestrated response include release of cytokines that induce acute-phase proteins, while other 'house-keeping' genes are downregulated. RECENT
FINDINGS: Although some acute-phase proteins help to control damage, functions of many other acute-phase reactants remain obscure. Changes in acute-phase gene expression are primarily subject to transcriptional regulation and can be comprehensively monitored by array techniques. Emerging evidence from such strategies implies that in addition to a 'common host response' also highly specific pathways are induced in specific disease contexts. Applying a systems biology approach to the integrated response of the hepatocyte to infection would suggest that the reprogramming of metabolic functions occurs in parallel with a severity-dependent disruption of phase I and II biotransformation and canalicular transport, that is, excretory failure. Although traditionally bilirubin serves to monitor excretion, emerging evidence suggests that bile acids indicate liver dysfunction with higher sensitivity and specificity.
SUMMARY: Sepsis induces reprogramming of the hepatic transcriptome. This includes induction of adaptive acute-phase proteins but also repression of phase I, II metabolism and transport with important implications for monitoring and pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448974     DOI: 10.1097/MCC.0b013e32835eba6d

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  36 in total

1.  Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation.

Authors:  Inga Wessels; Robert J Cousins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-13       Impact factor: 4.052

Review 2.  Hepatocytes as Immunological Agents.

Authors:  Ian N Crispe
Journal:  J Immunol       Date:  2016-01-01       Impact factor: 5.422

3.  Adaptation of HepG2 cells to a steady-state reduction in the content of protein phosphatase 6 (PP6) catalytic subunit.

Authors:  Joan M Boylan; Arthur R Salomon; Umadevi Tantravahi; Philip A Gruppuso
Journal:  Exp Cell Res       Date:  2015-05-18       Impact factor: 3.905

Review 4.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

5.  Inhibition of jejunal protein synthesis and breakdown in Pseudomonas aeruginosa-induced sepsis pig model.

Authors:  Gabriëlla A M Ten Have; Mariëlle P K J Engelen; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-04-12       Impact factor: 4.052

6.  Liver Function, Quantified by LiMAx Test, After Major Abdominal Surgery. Comparison Between Open and Laparoscopic Approach.

Authors:  Magnus Kaffarnik; Gabriel Stoeger; Julia Liebich; Christian Grieser; Johann Pratschke; Martin Stockmann
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

7.  Acute phase proteins and stress hormone responses in patients with newly diagnosed active pulmonary tuberculosis.

Authors:  J O Opolot; A J Theron; R Anderson; C Feldman
Journal:  Lung       Date:  2014-12-31       Impact factor: 2.584

8.  Identification of Metabolic Changes in Ileum, Jejunum, Skeletal Muscle, Liver, and Lung in a Continuous I.V. Pseudomonas aeruginosa Model of Sepsis Using Nontargeted Metabolomics Analysis.

Authors:  Amro Ilaiwy; Gabriella A M Ten Have; James R Bain; Michael J Muehlbauer; Sara K O'Neal; Jessica M Berthiaume; Traci L Parry; Nicolaas E Deutz; Monte S Willis
Journal:  Am J Pathol       Date:  2019-09       Impact factor: 4.307

Review 9.  Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; María Luisa Gutiérrez-García; Sonia Alonso-López; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 10.  Overview on acute-on-chronic liver failure.

Authors:  Jing Zhang; Shan Gao; Zhongping Duan; Ke-Qin Hu
Journal:  Front Med       Date:  2016-03-14       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.